Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas
Authors
Keywords
-
Journal
BLOOD
Volume 117, Issue 25, Pages 6856-6865
Publisher
American Society of Hematology
Online
2011-05-05
DOI
10.1182/blood-2011-01-330852
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Belimumab: A BLyS-Specific Inhibitor for Systemic Lupus Erythematosus
- (2010) Amy K Wiglesworth et al. ANNALS OF PHARMACOTHERAPY
- Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow
- (2010) O. Winter et al. BLOOD
- A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation
- (2009) M. Gupta et al. BLOOD
- The microenvironment in mature B-cell malignancies: a target for new treatment strategies
- (2009) J. A. Burger et al. BLOOD
- APRIL is overexpressed in cancer: link with tumor progression
- (2009) Jérôme Moreaux et al. BMC CANCER
- APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop
- (2009) Jérôme Moreaux et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking
- (2009) Fiona C. Kimberley et al. FASEB JOURNAL
- Pharmacokinetics and immunoglobulin response of subcutaneous and intravenous atacicept in patients with systemic lupus erythematosus
- (2009) I. Nestorov et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus
- (2009) C Pena-Rossi et al. LUPUS
- APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells
- (2008) E. Belnoue et al. BLOOD
- Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy
- (2008) Seok Jin Kim et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Thymus-independent class switch recombination is affected by APRIL
- (2008) Gijs Hardenberg et al. IMMUNOLOGY AND CELL BIOLOGY
- “APRIL hath put a spring of youth in everything”: Relevance of APRIL for survival
- (2008) Fiona C. Kimberley et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia
- (2008) Stefano Molica et al. LEUKEMIA RESEARCH
- Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus
- (2008) Richard Furie et al. ARTHRITIS RESEARCH & THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now